https://www.who.int/zh/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed 26 February 2020.
[4] National Health Commission of the People’s Republic of China. Notice on the issuance of COVID-19 ’s diagnosis and treatment plan (version 6). Available at:http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.Accessed 03 March 2020.
[5] National Health Commission of the People’s Republic of China. Notice on the issuance of COVID-19 ’s diagnosis and treatment plan (version 7). Available at:http://www.nhc.gov.cn/jkj/s3577/202003/4856d5b0458141fa9f376853224d41d7.shtml.Accessed 07 March 2020
[6] Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA, 2020, 323(14): 1406-1407.
[7] The latest situation of COVID-19 epidemic situation. National Health Commission of the People’s Republic of China. Available at:http://www.nhc.gov.cn/. Accessed 21 August 2020
[8] Li Ping, Li Zhiyong Li, Zhao silin, et al. Preliminary study of serum 2019⁃nCoV IgM and IgG antibodies in the diagnosis of COVID⁃19. Clin J Lab Med, 2020, 4(43): 352-357.
[9] Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med, 2020, 26(8): 1200-1204.
[10] Xiang F, Wang X, He X, et al. Antibody Detection and Dynamic Characteristics in Patients with COVID-19 [published online ahead of print, 2020 Apr 19]. Clin Infect Dis, 2020, ciaa461. doi:10.1093/cid/ciaa461